CoraLite®594-conjugated ITM2C Monoclonal antibody

ITM2C Monoclonal Antibody for IF/ICC
Cat No. CL594-60095

产品说明书

CloneNo. 2E8G11

宿主/亚型

Mouse / IgG2a

种属反应性

human, canine

应用

IF/ICC

E25, CT-BRI3, Cerebral protein 14, BRICD2C, BRI3

缓冲液配方:  PBS and Azide
PBS and Azide
偶联物:  CoraLite®594
规格: 

-/ -


经过测试的应用

Positive IF/ICC detected inHepG2 cells, MDCK cells
For other applications, we recommend the unconjugated version of this antibody, 60095-1-Ig

推荐稀释比

应用推荐稀释比
Immunofluorescence (IF)/ICCIF/ICC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

CL594-60095 targets ITM2C in IF/ICC applications and shows reactivity with human, canine samples.

经测试应用 IF/ICC Application Description
经测试反应性 human, canine
免疫原 ITM2C fusion protein Ag4409 种属同源性预测
宿主/亚型 Mouse / IgG2a
抗体类别 Monoclonal
产品类型 Antibody
全称 integral membrane protein 2C
别名 E25, CT-BRI3, Cerebral protein 14, BRICD2C, BRI3
计算分子量230aa,26 kDa; 267aa,30 kDa
观测分子量 35 kDa
GenBank蛋白编号BC025742
基因名称 ITM2C
Gene ID (NCBI) 81618
RRIDAB_2883421
偶联类型 CoraLite®594 Fluorescent Dye
最大激发/发射波长588 nm / 604 nm
形式 Liquid
纯化方式Protein A purification
UNIPROT IDQ9NQX7
储存缓冲液 PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA , pH 7.3
储存条件Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

The Integral membrane protein 2C (ITM2C) is a type II integral transmembrane protein belonging to a family composed of at least two other members, ITM2A and ITM2B. ITM2C, often called transmembrane protein BRI3, is highly expressed in brain tissue. Yeast two-hybrid screen system revealed that BRI3 could interact with beta-secretase beta-amyloid protein converting enzyme (BACE)1 and the microtubule-destabilizing protein SCG10 (STMN2). It may play a role in TNF-induced cell death and neuronal differentiation. BRI3 was found to inhibit the various processing of amyloid precursor protein (APP) by blocking the access of alpha- and beta-secretases to APP, competitive inhibition of APP processing by BRI3 may provide a new approach to Alzheimer disease (AD) therapy and prevention.

实验方案

Product Specific Protocols
IF protocol for CL594 ITM2C antibody CL594-60095Download protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...